Hi Axbci. I tend to disagree with you on point that the issue of the certificate is of the utmost importance. Because as the company has announced some MOUs and purchase orders are contingent on the Chinese factory beginning production. The company's ability to convert MOUs into revenue will be the single greatest sp rerate in the short term. It will provide a huge amount of credibility and provide much needed revenue. If the company cannot convert these MOUs and purchase orders into revenue then we are in huge trouble. The ability to move into product as soon as the certificate is issue is key. It will take 6 months plus to recover from such a disaster. Don't get me wrong the long term potential of this is still huge. It is crunch time and Yacov has to walk the walk now!
- Forums
- ASX - By Stock
- GMV
- Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility
Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility, page-268
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online